Sign in to view content

Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations

Seenu M. Hariprasad, MD

Video
Published 2019

Related

2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)
Nancy M. Holekamp, MD, FASRS
Annual Meeting Talks
2018
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema
Raj K. Maturi, MD
Annual Meeting Talks
2018
Interim 12-Month Results from PALADIN in Diabetic Macular Patients Receiving ILUVIEN: Analysis of the Prior Dexamethasone Cohort
Daniel F. Kiernan, MD, FACS
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more